ArticleBioengineered2022

A novel ribosomal protein S6 kinase 2 inhibitor attenuates the malignant phenotype of cutaneous malignant melanoma cells by inducing cell cycle arrest and apoptosis.

Yayun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.